These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 1594278
41. Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. Cabbell KL, Taren JA, Sagher O. Neurosurgery; 1998 May; 42(5):1176-80; discussion 1180-1. PubMed ID: 9588567 [Abstract] [Full Text] [Related]
42. Postoperative continuous intrathecal pain treatment in children after selective dorsal rhizotomy with bupivacaine and two different morphine doses. Hesselgard K, Strömblad LG, Romner B, Reinstrup P. Paediatr Anaesth; 2006 Apr; 16(4):436-43. PubMed ID: 16618299 [Abstract] [Full Text] [Related]
43. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain. Liu HJ, Gao XZ, Liu XM, Xia M, Li WY, Jin Y. J Palliat Med; 2014 Jul; 17(7):837-40. PubMed ID: 24702571 [Abstract] [Full Text] [Related]
46. Intrathecal morphine combined with ropivacaine induces spinal myoclonus in cancer patients with an implanted intrathecal drug delivery system: Three case reports. Guo X, Li Y, Yang Y, Zhao Y, Guo J, Zhang Y, Peng Z, Feng Z. Medicine (Baltimore); 2019 May; 98(18):e15330. PubMed ID: 31045772 [Abstract] [Full Text] [Related]
47. [Pain relief by epidural and intrathecal application of morphine]. Rosenberg P, Scheinin B, Kalso E. Nord Med; 1983 May; 98(11):263-5. PubMed ID: 6197695 [No Abstract] [Full Text] [Related]
49. Management of patients with pain and severe side effects while on intrathecal morphine therapy: A case study. Zhou K, Sheng S, Wang GG. Scand J Pain; 2017 Oct; 17():37-40. PubMed ID: 28850371 [Abstract] [Full Text] [Related]
51. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience. Lin CP, Lin WY, Lin FS, Lee YS, Jeng CS, Sun WZ. J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395 [Abstract] [Full Text] [Related]
52. [Pain treatment by sub or epidural opiate administration]. Grabow L. Anasth Intensivther Notfallmed; 1982 Jun; 17(3):161-4. PubMed ID: 6896965 [Abstract] [Full Text] [Related]
53. Intrathecal pain pump infusions for intractable cancer pain: an algorithm for dosing without a neuraxial trial. Malhotra VT, Root J, Kesselbrenner J, Njoku I, Cubert K, Gulati A, Puttanniah V, Bilsky M, Kaplitt M. Anesth Analg; 2013 Jun; 116(6):1364-70. PubMed ID: 23558833 [Abstract] [Full Text] [Related]
54. [Continuous intrathecal analgesia in terminal cancer patients within transmural health care]. Wagemans MF, Spoelder EM, Zuurmond WW, de Lange JJ. Ned Tijdschr Geneeskd; 1993 Jul 31; 137(31):1553-7. PubMed ID: 7690112 [Abstract] [Full Text] [Related]
55. Neuraxial infusion in patients with chronic intractable cancer and noncancer pain. Osenbach RK, Harvey S. Curr Pain Headache Rep; 2001 Jun 31; 5(3):241-9. PubMed ID: 11309212 [Abstract] [Full Text] [Related]
56. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series. Kongkam P, Wagner DL, Sherman S, Fogel EL, Whittaker SC, Watkins JL, McHenry L, Lehman GA. Am J Gastroenterol; 2009 May 31; 104(5):1249-55. PubMed ID: 19367269 [Abstract] [Full Text] [Related]
57. Efficacy of intrathecal bupivacaine: how important is the flow rate? Buchser E, Durrer A, Chédel D, Mustaki JP. Pain Med; 2004 Sep 31; 5(3):248-52. PubMed ID: 15367302 [Abstract] [Full Text] [Related]